Company page
Opus Genetics, Inc.
Opus Genetics, Inc. is a public company traded under the ticker IRD in the American market. The company has a market capitalization of approximately $336 million. Opus Genetics focuses on developing innovative therapies in the field of genetic medicine.
- Ticker
- IRD:NASDAQ
- Asset type
- Stock
- Market cap
- $336.0M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD